CHRISTOPHER QUIRANTE: Open Payments
NPI 1447213368 · VIDOR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 25 payments from 8 companies in 2025. Trend: 2023 $705 · 2024 $595 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $152 |
| Novo Nordisk Inc | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Astellas Pharma US Inc | 3 | $45 |
| Exact Sciences Corporation | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| Corcept Therapeutics | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: UBRELVY, Veozah, QULIPTA, Ozempic, Rybelsus, The Cologuard Plus Collection Kit, FARXIGA, Wegovy.
Industry payments across TX — which companies pay providers there.
